Healthcare & Pharmaceuticals
MiBiome topical suspension
ClearSkin developed a completely new and unique therapy for treating chronic inflammatory skin diseases (e.g., psoriasis, atopic dermatitis, pruritus) using a novel topical probio
Field of Expertise
Cosmetic product for dry,irritaded,red skin- based on microbiome management
Expertise
ClearSkin developed a completely new and unique therapy for treating chronic inflammatory skin diseases (e.g., psoriasis, atopic dermatitis, pruritus) using a novel topical probiotic for balancing and modulating the dermal microbiome (the populations of microorganisms – bacteria, yeasts and viruses, that naturally live on our skin). In a small clinical study the product was shown to be effective in >80% of psoriatic patients within 8 weeks of treatment. MiBiome is over 2.5years commercial, great resilts were observed with atopic dermatitis. The product is a topical suspension based on olive oil and innovative probiotics for application twice daily It is all natural and (obviously) contains no steroids, parabens, SLS/SLES or dyes PCT filed Received a grant from the Israel Innovation Authority Approved as a cosmetic product by the Israeli MoH, centrally across Europe by CPNP notification process and by Philippines FDA, follows USA FDA voluntary regulation The product is commercially available in Israel in pharmacies and natural products stores (about 200 points of sale) Available on Amazon US Free sale certificate available The company is looking for: Distribution partnerships to expand its presence with currently commercial cosmetic product MiBiome Advanced Topical Suspension.